Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Maravai Lifesciences 18M share Secondary priced at $31.25 » 20:29
04/07/21
04/07
20:29
04/07/21
20:29
MRVI

Maravai Lifesciences

$32.47 /

-0.34 (-1.04%)

The deal size was…

The deal size was increased from 15M shares and priced below the last closing price of $32.46. Morgan Stanley, Jefferies and Goldman Sachs are acting as joint book running managers for the offering.

ShowHide Related Items >><<
MRVI Maravai Lifesciences
$32.47 /

-0.34 (-1.04%)

MRVI Maravai Lifesciences
$32.47 /

-0.34 (-1.04%)

03/03/21 Morgan Stanley
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley
03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
MRVI Maravai Lifesciences
$32.47 /

-0.34 (-1.04%)

  • 08
    Apr
  • 20
    Nov
MRVI Maravai Lifesciences
$32.47 /

-0.34 (-1.04%)

MRVI Maravai Lifesciences
$32.47 /

-0.34 (-1.04%)

Over a week ago
On The Fly
Fly Intel: After-Hours Movers » 19:16
04/05/21
04/05
19:16
04/05/21
19:16
ICAD

iCAD

$19.96 /

+0.04 (+0.20%)

, ILMN

Illumina

$384.41 /

-0.72 (-0.19%)

, SPNE

SeaSpine

$17.93 /

+0.23 (+1.30%)

, DCT

Duck Creek Technologies

$44.50 /

-0.5 (-1.11%)

, GBOX

GreenBox

$15.36 /

+1.47 (+10.58%)

, OPNT

Opiant Pharmaceuticals

$11.15 /

+0.49 (+4.60%)

, MRVI

Maravai Lifesciences

$34.59 /

+0.4 (+1.17%)

, PSX

Phillips 66

$82.06 /

-1.08 (-1.30%)

, ARES

Ares Management

$59.12 /

+1.59 (+2.76%)

, TPTX

Turning Point Therapeutics

$89.91 /

-0.7 (-0.77%)

, UCTT

Ultra Clean

$64.92 /

+1.37 (+2.16%)

, USAT

USA Technologies

$12.77 /

+0.76 (+6.33%)

Check out this evening's…

ShowHide Related Items >><<
USAT USA Technologies
$12.77 /

+0.76 (+6.33%)

UCTT Ultra Clean
$64.92 /

+1.37 (+2.16%)

TPTX Turning Point Therapeutics
$89.91 /

-0.7 (-0.77%)

SPNE SeaSpine
$17.93 /

+0.23 (+1.30%)

PSX Phillips 66
$82.06 /

-1.08 (-1.30%)

OPNT Opiant Pharmaceuticals
$11.15 /

+0.49 (+4.60%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

ILMN Illumina
$384.41 /

-0.72 (-0.19%)

ICAD iCAD
$19.96 /

+0.04 (+0.20%)

GBOX GreenBox
$15.36 /

+1.47 (+10.58%)

DCT Duck Creek Technologies
$44.50 /

-0.5 (-1.11%)

ARES Ares Management
$59.12 /

+1.59 (+2.76%)

ICAD iCAD
$19.96 /

+0.04 (+0.20%)

03/23/21 BTIG
iCAD initiated with a Buy at BTIG
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
02/26/21 B. Riley
iCAD price target raised to $23 from $18 at B. Riley Securities
02/25/21 Oppenheimer
iCAD initiated with an Outperform at Oppenheimer
ILMN Illumina
$384.41 /

-0.72 (-0.19%)

04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
03/31/21 Canaccord
Canaccord upgrades Illumina, says worth owning with or without Grail
03/31/21 Canaccord
Illumina upgraded to Buy from Hold at Canaccord
03/31/21 Atlantic Equities
Illumina downgraded to Neutral from Overweight at Atlantic Equities
SPNE SeaSpine
$17.93 /

+0.23 (+1.30%)

03/24/21 Canaccord
Canaccord likes what 7D acquisition brings to SeaSpine Holdings
03/02/21 Canaccord
SeaSpine price target raised to $25 from $23 at Canaccord
03/01/21 Piper Sandler
SeaSpine price target raised to $28 from $22 at Piper Sandler
01/29/21 Piper Sandler
SeaSpine price target raised to $22 from $18 at Piper Sandler
DCT Duck Creek Technologies
$44.50 /

-0.5 (-1.11%)

01/13/21 Goldman Sachs
Sapiens initiated with a Neutral at Goldman Sachs
10/21/20 RBC Capital
Duck Creek Technologies price target raised to $51 from $45 at RBC Capital
10/21/20 Barclays
Duck Creek Technologies price target raised to $48 from $43 at Barclays
09/08/20 DA Davidson
Duck Creek Technologies initiated with a Buy at DA Davidson
GBOX GreenBox
$15.36 /

+1.47 (+10.58%)

OPNT Opiant Pharmaceuticals
$11.15 /

+0.49 (+4.60%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

03/03/21 Morgan Stanley
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley
03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
PSX Phillips 66
$82.06 /

-1.08 (-1.30%)

04/01/21
Fly Intel: Top five analyst downgrades
04/01/21 Piper Sandler
Phillips 66 downgraded to Neutral on valuation at Piper Sandler
04/01/21 Piper Sandler
Phillips 66 downgraded to Neutral from Overweight at Piper Sandler
03/17/21 Citi
Phillips 66 price target raised to $99 from $81 at Citi
ARES Ares Management
$59.12 /

+1.59 (+2.76%)

03/29/21
Fly Intel: Top five analyst downgrades
03/29/21 BMO Capital
Ares Management downgraded to Market Perform from Outperform at BMO Capital
02/24/21 Credit Suisse
Ares Management re-initiated with a Neutral at Credit Suisse
02/12/21 Barclays
Ares Management price target raised to $58 from $56 at Barclays
TPTX Turning Point Therapeutics
$89.91 /

-0.7 (-0.77%)

03/02/21 Roth Capital
Turning Point has 'many value-driving catalysts' in 2021, says Roth Capital
02/02/21 Canaccord
Turning Point Therapeutics price target raised to $145 from $122 at Canaccord
01/29/21 Roth Capital
Turning Point Therapeutics price target raised to $170 from $140 at Roth Capital
01/19/21 H.C. Wainwright
Turning Point Therapeutics price target raised to $190 from $130 at H.C. Wainwright
UCTT Ultra Clean
$64.92 /

+1.37 (+2.16%)

02/18/21 Needham
Ultra Clean price target raised to $55 from $43 at Needham
02/18/21 Craig-Hallum
Ultra Clean price target raised to $69 from $47 at Craig-Hallum
01/29/21 Cowen
Cowen upgrades Ultra Clean to Outperform on robust spending trends
01/29/21 Cowen
Ultra Clean upgraded to Outperform from Market Perform at Cowen
USAT USA Technologies
$12.77 /

+0.76 (+6.33%)

02/05/21 Lake Street
USA Technologies price target raised to $12 from $10 at Lake Street
01/06/21 Northland
USA Technologies named a top pick for 2021 at Northland
12/16/20 Northland
Northland upgrades 'recovery story' USA Technologies to Outperform
12/16/20 Northland
USA Technologies upgraded to Outperform from Market Perform at Northland
USAT USA Technologies
$12.77 /

+0.76 (+6.33%)

UCTT Ultra Clean
$64.92 /

+1.37 (+2.16%)

TPTX Turning Point Therapeutics
$89.91 /

-0.7 (-0.77%)

SPNE SeaSpine
$17.93 /

+0.23 (+1.30%)

PSX Phillips 66
$82.06 /

-1.08 (-1.30%)

OPNT Opiant Pharmaceuticals
$11.15 /

+0.49 (+4.60%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

ILMN Illumina
$384.41 /

-0.72 (-0.19%)

ICAD iCAD
$19.96 /

+0.04 (+0.20%)

DCT Duck Creek Technologies
$44.50 /

-0.5 (-1.11%)

ARES Ares Management
$59.12 /

+1.59 (+2.76%)

  • 09
    Apr
  • 08
    Apr
  • 06
    Apr
  • 03
    Mar
  • 17
    Feb
  • 29
    Jan
  • 20
    Nov
  • 11
    Nov
  • 27
    Oct
  • 14
    Aug
  • 19
    May
PSX Phillips 66
$82.06 /

-1.08 (-1.30%)

ILMN Illumina
$384.41 /

-0.72 (-0.19%)

USAT USA Technologies
$12.77 /

+0.76 (+6.33%)

UCTT Ultra Clean
$64.92 /

+1.37 (+2.16%)

SPNE SeaSpine
$17.93 /

+0.23 (+1.30%)

OPNT Opiant Pharmaceuticals
$11.15 /

+0.49 (+4.60%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

ILMN Illumina
$384.41 /

-0.72 (-0.19%)

ICAD iCAD
$19.96 /

+0.04 (+0.20%)

DCT Duck Creek Technologies
$44.50 /

-0.5 (-1.11%)

ARES Ares Management
$59.12 /

+1.59 (+2.76%)

USAT USA Technologies
$12.77 /

+0.76 (+6.33%)

PSX Phillips 66
$82.06 /

-1.08 (-1.30%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

ILMN Illumina
$384.41 /

-0.72 (-0.19%)

DCT Duck Creek Technologies
$44.50 /

-0.5 (-1.11%)

Syndicate
Maravai Lifesciences files to sell 15M shares of Class A common for holders » 17:11
04/05/21
04/05
17:11
04/05/21
17:11
MRVI

Maravai Lifesciences

$34.59 /

+0.4 (+1.17%)

Morgan Stanley,…

Morgan Stanley, Jefferies, and Goldman Sachs are managing the offering.

ShowHide Related Items >><<
MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

03/03/21 Morgan Stanley
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley
03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

  • 20
    Nov
MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

Earnings
Maravai Lifesciences sees Q1 revenue approximately $148M, consensus 1$48.68M » 16:21
04/05/21
04/05
16:21
04/05/21
16:21
MRVI

Maravai Lifesciences

$34.59 /

+0.4 (+1.17%)

Maravai LifeSciences…

Maravai LifeSciences Holdings provided preliminary unaudited revenue and Income from Operations estimates for the quarter ended March 31. Subject to quarter-end closing adjustments, the Company expects to report total revenues of approximately $148M for Q1, an increase of 190% compared to Q1 2020 and a sequential increase of 50% compared to Q4 2020. These preliminary results exceed the Company's most recent guidance provided on March 2, which projected Q1 sequential revenue growth over Q4 2020 in the range of 30% to 35%. The Company has not yet completed its financial close process for the first quarter of 2021; however, the Company expects Income from Operations ranging between $80M to $100M for the quarter. The financial information included in this press release is preliminary and subject to adjustment. It does not present all information necessary for an understanding of the Company's first quarter of 2021. The Company expects to report its completed financial results for the first quarter of 2021 in May 2021. "Maravai's strong momentum continued in the first quarter of 2021, primarily driven by the continued strength of our Nucleic Acid Production business," said Carl Hull, Chairman and CEO. "I am very proud of the ways in which our extraordinary team, and our partners, continue to scale meaningfully to address the global COVID-19 pandemic. We look forward to sharing our full financial results on our first quarter earnings release call scheduled for May 10," added Hull.

ShowHide Related Items >><<
MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

03/03/21 Morgan Stanley
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley
03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

  • 20
    Nov
MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

MRVI Maravai Lifesciences
$34.59 /

+0.4 (+1.17%)

Conference/Events
KeyBanc Capital Markets to hold a virtual forum » 04:55
03/24/21
03/24
04:55
03/24/21
04:55
INGN

Inogen

$47.52 /

-1.8 (-3.65%)

, RMD

ResMed

$190.70 /

+1.12 (+0.59%)

, HRC

Hill-Rom

$107.07 /

-1.77 (-1.63%)

, ENZ

Enzo Biochem

$3.50 /

-0.27 (-7.16%)

, ICUI

ICU Medical

$207.63 /

+0.75 (+0.36%)

, RCM

R1 RCM

$25.12 /

-0.14 (-0.55%)

, CNMD

Conmed

$122.08 /

-3.14 (-2.51%)

, MRVI

Maravai Lifesciences

$36.44 /

-0.49 (-1.33%)

, PINC

Premier

$33.32 /

-0.16 (-0.48%)

, BRKS

Brooks Automation

$78.43 /

-9.91 (-11.22%)

, IVC

Invacare

$8.03 /

-0.47 (-5.53%)

, AVNS

Avanos

$44.38 /

-0.75 (-1.66%)

Life Sciences &…

Life Sciences & MedTech Investor Virtual Forum to be held on March 23-24.

ShowHide Related Items >><<
RCM R1 RCM
$25.12 /

-0.14 (-0.55%)

PINC Premier
$33.32 /

-0.16 (-0.48%)

MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

IVC Invacare
$8.03 /

-0.47 (-5.53%)

INGN Inogen
$47.52 /

-1.8 (-3.65%)

HRC Hill-Rom
$107.07 /

-1.77 (-1.63%)

ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

CNMD Conmed
$122.08 /

-3.14 (-2.51%)

BRKS Brooks Automation
$78.43 /

-9.91 (-11.22%)

INGN Inogen
$47.52 /

-1.8 (-3.65%)

12/14/20 KeyBanc
Inogen upgraded to Overweight after management meetings at KeyBanc
12/14/20 KeyBanc
Inogen upgraded to Overweight from Sector Weight at KeyBanc
07/23/20
Fly Intel: Top five analyst downgrades
07/23/20 Needham
Needham downgrades Inogen to Hold on concerns over DTC business
RMD ResMed
$190.70 /

+1.12 (+0.59%)

03/16/21 Needham
ResMed upgraded to Buy from Hold at Needham
03/16/21 Needham
ResMed upgraded to Buy from Hold at Needham
10/30/20 JPMorgan
ResMed upgraded to Neutral on sleep sector recovery at JPMorgan
10/30/20 Credit Suisse
ResMed upgraded to Outperform from Neutral at Credit Suisse
HRC Hill-Rom
$107.07 /

-1.77 (-1.63%)

02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
11/04/20
Fly Intel: Top five analyst downgrades
11/04/20
Hill-Rom cut to Hold at Needham, expecting 'lost year' in FY21
ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

ICUI ICU Medical
$207.63 /

+0.75 (+0.36%)

09/02/20 KeyBanc
ICU Medical price target raised to $218 from $199 at KeyBanc
05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
RCM R1 RCM
$25.12 /

-0.14 (-0.55%)

02/16/21 KeyBanc
R1 RCM price target raised to $35 from $27 at KeyBanc
02/09/21 Cowen
R1 RCM price target raised to $33 from $22 at Cowen
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
12/09/20 RBC Capital
R1 RCM price target raised to $27 from $20 at RBC Capital
CNMD Conmed
$122.08 /

-3.14 (-2.51%)

01/28/21 Piper Sandler
Conmed price target raised to $145 from $95 at Piper Sandler
09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

03/03/21 Morgan Stanley
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley
03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
PINC Premier
$33.32 /

-0.16 (-0.48%)

02/04/21 Piper Sandler
Premier price target raised to $36 from $32 at Piper Sandler
02/04/21 Truist
Premier price target raised to $38 from $33 at Truist
02/03/21 Benchmark
Premier upgraded to Buy from Hold at Benchmark
01/19/21 BofA
Premier double-downgraded to Underperform from Buy at BofA
BRKS Brooks Automation
$78.43 /

-9.91 (-11.22%)

02/10/21 KeyBanc
Brooks Automation price target raised to $111 from $99 at KeyBanc
02/03/21 Credit Suisse
Brooks Automation price target raised to $70 from $58 at Credit Suisse
02/03/21 B. Riley
Brooks Automation price target raised to $105 from $100 at B. Riley Securities
02/03/21 KeyBanc
Brooks Automation price target raised to $99 from $75 at KeyBanc
IVC Invacare
$8.03 /

-0.47 (-5.53%)

AVNS Avanos
$44.38 /

-0.75 (-1.66%)

04/13/20 Barclays
Avanos upgraded to Equal Weight from Underweight at Barclays
RMD ResMed
$190.70 /

+1.12 (+0.59%)

RCM R1 RCM
$25.12 /

-0.14 (-0.55%)

PINC Premier
$33.32 /

-0.16 (-0.48%)

MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

IVC Invacare
$8.03 /

-0.47 (-5.53%)

INGN Inogen
$47.52 /

-1.8 (-3.65%)

ICUI ICU Medical
$207.63 /

+0.75 (+0.36%)

HRC Hill-Rom
$107.07 /

-1.77 (-1.63%)

ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

CNMD Conmed
$122.08 /

-3.14 (-2.51%)

BRKS Brooks Automation
$78.43 /

-9.91 (-11.22%)

AVNS Avanos
$44.38 /

-0.75 (-1.66%)

  • 20
    Nov
RMD ResMed
$190.70 /

+1.12 (+0.59%)

MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

INGN Inogen
$47.52 /

-1.8 (-3.65%)

ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

CNMD Conmed
$122.08 /

-3.14 (-2.51%)

BRKS Brooks Automation
$78.43 /

-9.91 (-11.22%)

RMD ResMed
$190.70 /

+1.12 (+0.59%)

MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

Conference/Events
KeyBanc Capital Markets to hold a virtual forum » 10:19
03/23/21
03/23
10:19
03/23/21
10:19
INGN

Inogen

$48.29 /

-1.03 (-2.09%)

, RMD

ResMed

$190.03 /

+0.45 (+0.24%)

, HRC

Hill-Rom

$107.37 /

-1.47 (-1.35%)

, ENZ

Enzo Biochem

$3.60 /

-0.17 (-4.51%)

, ICUI

ICU Medical

$208.87 /

+1.99 (+0.96%)

, RCM

R1 RCM

$24.92 /

-0.34 (-1.35%)

, CNMD

Conmed

$122.66 /

-2.56 (-2.04%)

, MRVI

Maravai Lifesciences

$36.38 /

-0.55 (-1.49%)

, PINC

Premier

$33.29 /

-0.19 (-0.57%)

, BRKS

Brooks Automation

$86.00 /

-2.34 (-2.65%)

, IVC

Invacare

$8.32 /

-0.18 (-2.12%)

, AVNS

Avanos

$44.65 /

-0.48 (-1.06%)

Life Sciences &…

Life Sciences & MedTech Investor Virtual Forum to be held on March 23-24.

ShowHide Related Items >><<
RCM R1 RCM
$24.92 /

-0.34 (-1.35%)

PINC Premier
$33.29 /

-0.19 (-0.57%)

MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

IVC Invacare
$8.32 /

-0.18 (-2.12%)

INGN Inogen
$48.29 /

-1.03 (-2.09%)

HRC Hill-Rom
$107.37 /

-1.47 (-1.35%)

ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

CNMD Conmed
$122.66 /

-2.56 (-2.04%)

BRKS Brooks Automation
$86.00 /

-2.34 (-2.65%)

INGN Inogen
$48.29 /

-1.03 (-2.09%)

12/14/20 KeyBanc
Inogen upgraded to Overweight after management meetings at KeyBanc
12/14/20 KeyBanc
Inogen upgraded to Overweight from Sector Weight at KeyBanc
07/23/20
Fly Intel: Top five analyst downgrades
07/23/20 Needham
Needham downgrades Inogen to Hold on concerns over DTC business
RMD ResMed
$190.03 /

+0.45 (+0.24%)

03/16/21 Needham
ResMed upgraded to Buy from Hold at Needham
03/16/21 Needham
ResMed upgraded to Buy from Hold at Needham
10/30/20 JPMorgan
ResMed upgraded to Neutral on sleep sector recovery at JPMorgan
10/30/20 Credit Suisse
ResMed upgraded to Outperform from Neutral at Credit Suisse
HRC Hill-Rom
$107.37 /

-1.47 (-1.35%)

02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
11/04/20
Fly Intel: Top five analyst downgrades
11/04/20
Hill-Rom cut to Hold at Needham, expecting 'lost year' in FY21
ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

ICUI ICU Medical
$208.87 /

+1.99 (+0.96%)

09/02/20 KeyBanc
ICU Medical price target raised to $218 from $199 at KeyBanc
05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
RCM R1 RCM
$24.92 /

-0.34 (-1.35%)

02/16/21 KeyBanc
R1 RCM price target raised to $35 from $27 at KeyBanc
02/09/21 Cowen
R1 RCM price target raised to $33 from $22 at Cowen
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
12/09/20 RBC Capital
R1 RCM price target raised to $27 from $20 at RBC Capital
CNMD Conmed
$122.66 /

-2.56 (-2.04%)

01/28/21 Piper Sandler
Conmed price target raised to $145 from $95 at Piper Sandler
09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

03/03/21 Morgan Stanley
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley
03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
PINC Premier
$33.29 /

-0.19 (-0.57%)

02/04/21 Piper Sandler
Premier price target raised to $36 from $32 at Piper Sandler
02/04/21 Truist
Premier price target raised to $38 from $33 at Truist
02/03/21 Benchmark
Premier upgraded to Buy from Hold at Benchmark
01/19/21 BofA
Premier double-downgraded to Underperform from Buy at BofA
BRKS Brooks Automation
$86.00 /

-2.34 (-2.65%)

02/10/21 KeyBanc
Brooks Automation price target raised to $111 from $99 at KeyBanc
02/03/21 Credit Suisse
Brooks Automation price target raised to $70 from $58 at Credit Suisse
02/03/21 B. Riley
Brooks Automation price target raised to $105 from $100 at B. Riley Securities
02/03/21 KeyBanc
Brooks Automation price target raised to $99 from $75 at KeyBanc
IVC Invacare
$8.32 /

-0.18 (-2.12%)

AVNS Avanos
$44.65 /

-0.48 (-1.06%)

04/13/20 Barclays
Avanos upgraded to Equal Weight from Underweight at Barclays
RMD ResMed
$190.03 /

+0.45 (+0.24%)

RCM R1 RCM
$24.92 /

-0.34 (-1.35%)

PINC Premier
$33.29 /

-0.19 (-0.57%)

MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

IVC Invacare
$8.32 /

-0.18 (-2.12%)

INGN Inogen
$48.29 /

-1.03 (-2.09%)

ICUI ICU Medical
$208.87 /

+1.99 (+0.96%)

HRC Hill-Rom
$107.37 /

-1.47 (-1.35%)

ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

CNMD Conmed
$122.66 /

-2.56 (-2.04%)

BRKS Brooks Automation
$86.00 /

-2.34 (-2.65%)

AVNS Avanos
$44.65 /

-0.48 (-1.06%)

  • 20
    Nov
RMD ResMed
$190.03 /

+0.45 (+0.24%)

MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

INGN Inogen
$48.29 /

-1.03 (-2.09%)

ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

CNMD Conmed
$122.66 /

-2.56 (-2.04%)

BRKS Brooks Automation
$86.00 /

-2.34 (-2.65%)

RMD ResMed
$190.03 /

+0.45 (+0.24%)

MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

Over a month ago
Recommendations
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley » 09:39
03/03/21
03/03
09:39
03/03/21
09:39
MRVI

Maravai Lifesciences

$35.01 /

-1.43 (-3.92%)

Morgan Stanley analyst…

Morgan Stanley analyst Tejas Savant raised the firm's price target on Maravai Lifesciences to $54 from $35 and keeps an Overweight rating on the shares after the company reported "strong" Q4 results and management gave a "blowout" outlook that "far surpassed bullish expectations." However, despite CleanCap expectations that yielded 2021 guidance significantly above Street forecasts, Tejas still sees "ample room for upside," the analyst tells investors.

ShowHide Related Items >><<
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
12/16/20 KeyBanc
Maravai Lifesciences initiated with an Overweight at KeyBanc
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

  • 20
    Nov
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

Recommendations
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc » 08:27
03/03/21
03/03
08:27
03/03/21
08:27
MRVI

Maravai Lifesciences

$35.01 /

-1.43 (-3.92%)

KeyBanc analyst Paul…

KeyBanc analyst Paul Knight raised the firm's price target on Maravai Lifesciences to $46 from $39 and keeps an Overweight rating on the shares. The analyst notes Q4 results exceeded estimates, and guidance of $580M-$630M was significant compared to his above consensus estimates of $445M. Furthermore, the company is seeing increased visibility into fiscal year 2022 due to potential vaccine booster demand and momentum for other vaccine and therapeutic mRNA programs, Knight adds.

ShowHide Related Items >><<
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
12/16/20 KeyBanc
Maravai Lifesciences initiated with an Overweight at KeyBanc
12/15/20 Morgan Stanley
Maravai Lifesciences initiated with an Overweight at Morgan Stanley
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

  • 20
    Nov
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

Recommendations
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse » 07:52
03/03/21
03/03
07:52
03/03/21
07:52
MRVI

Maravai Lifesciences

$35.01 /

-1.43 (-3.92%)

Credit Suisse analyst…

Credit Suisse analyst Erin Wilson Wright raised the firm's price target on Maravai Lifesciences to $42 from $34 and keeps an Outperform rating on the shares following quarterly results. While Maravai Lifesciences' shares have increased 30% since its mid-November IPO, albeit with meaningful share volatility related to COVID-19 news flow, the analyst expects momentum should continue with the latest Q4 outperformance and notably better-than-expected guidance, which seems to still embed a notable level of upside opportunity.

ShowHide Related Items >><<
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
12/16/20 KeyBanc
Maravai Lifesciences initiated with an Overweight at KeyBanc
12/15/20 Morgan Stanley
Maravai Lifesciences initiated with an Overweight at Morgan Stanley
12/15/20 Baird
Baird starts Maravai Lifesciences at Outperform with $31 price target
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

  • 20
    Nov
MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

On The Fly
Fly Intel: After-Hours Movers » 19:16
03/02/21
03/02
19:16
03/02/21
19:16
MRVI

Maravai Lifesciences

$35.01 /

-1.43 (-3.92%)

, AMBA

Ambarella

$113.78 /

-4.91 (-4.14%)

, QTRX

Quanterix

$77.06 /

-5.61 (-6.79%)

, LYFT

Lyft

$57.06 /

-0.26 (-0.45%)

, FUBO

FuboTV

$41.96 /

+3.24 (+8.37%)

, BGS

B&G Foods

$30.44 /

-0.36 (-1.17%)

, GO

Grocery Outlet

$36.12 /

+0.19 (+0.53%)

, VEC

Vectrus

$55.59 /

+0.89 (+1.63%)

, ROST

Ross Stores

$117.75 /

-2.63 (-2.18%)

, NVEE

NV5 Global

$102.47 /

-2.59 (-2.47%)

, REAL

RealReal

$26.70 /

-1.48 (-5.25%)

, RVMD

Revolution Medicines

$44.36 /

-1.57 (-3.42%)

, JWN

Nordstrom

$37.45 /

-0.5 (-1.32%)

, URBN

Urban Outfitters

$33.75 /

-0.4 (-1.17%)

, ARNA

Arena Pharmaceuticals

$76.67 /

-3.44 (-4.29%)

, SSYS

Stratasys

$32.27 /

-4.12 (-11.32%)

, ICAD

iCAD

$18.88 /

-0.3 (-1.56%)

, ABNB

Airbnb

$189.68 /

-6.16 (-3.15%)

Check out this evening's…

ShowHide Related Items >><<
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ICAD iCAD
$18.88 /

-0.3 (-1.56%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
12/16/20 KeyBanc
Maravai Lifesciences initiated with an Overweight at KeyBanc
12/15/20 Morgan Stanley
Maravai Lifesciences initiated with an Overweight at Morgan Stanley
12/15/20 Baird
Baird starts Maravai Lifesciences at Outperform with $31 price target
AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

02/24/21 Deutsche Bank
Ambarella price target raised to $100 from $75 at Deutsche Bank
01/21/21 Stifel
Ambarella price target raised to $118 from $110 at Stifel
01/13/21 Roth Capital
Ambarella upgraded to Buy with $130 price target at Roth Capital
01/13/21 Roth Capital
Ambarella upgraded to Buy from Neutral at Roth Capital
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
LYFT Lyft
$57.06 /

-0.26 (-0.45%)

02/11/21 KeyBanc
Uber price target raised to $75 from $63 at KeyBanc
02/11/21 Needham
Needham transfers coverage on Lyft, raises price target $70 from $50
02/10/21 DA Davidson
Lyft price target raised to $66 from $58 at DA Davidson
02/10/21 Jefferies
Lyft price target raised to $75 from $70 at Jefferies
FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

02/01/21 Wedbush
FuboTV price target raised to $50 from $40 at Wedbush
01/21/21 Barrington
FuboTV initiated with an Outperform at Barrington
01/19/21 LightShed Partners
FuboTV price target lowered to $6.50 from $8 at LightShed Partners
01/12/21 Roth Capital
FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital
BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
01/05/21 Credit Suisse
B&G Foods downgraded to Underperform from Neutral at Credit Suisse
07/28/20 Seaport Global
B&G Foods initiated with a Neutral at Seaport Global
06/12/20
Fly Intel: Top five analyst initiations
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

11/18/20 Berenberg
Grocery Outlet initiated with a Buy at Berenberg
11/11/20 DA Davidson
Grocery Outlet price target lowered to $50 from $53 at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

05/19/20 B. Riley
B. Riley FBR sees path for Vectrus shares to top $70
03/05/20 B. Riley
Vectrus price target raised to $60 from $55 at B. Riley FBR
03/04/20 Noble Capital
Vectrus upgraded to Outperform from Market Perform at Noble Capital
ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

01/21/21 Deutsche Bank
Ross Stores price target raised to $129 from $123 at Deutsche Bank
01/04/21 JPMorgan
Ross Stores price target raised to $128 from $125 at JPMorgan
11/20/20 MKM Partners
Ross Stores price target raised to $124 from $105 at MKM Partners
11/20/20 Loop Capital
Ross Stores price target raised to $130 from $110 at Loop Capital
NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

01/13/21 Roth Capital
NV5 Global price target raised to $136 from $82 at Roth Capital
11/12/20 Roth Capital
NV5 Global price target raised to $82 from $77 at Roth Capital
08/24/20
Fly Intel: Top five analyst upgrades
08/24/20 Sidoti
Sidoti upgrades NV5 Global to Buy following pullback
REAL RealReal
$26.70 /

-1.48 (-5.25%)

02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 BTIG
RealReal price target raised to $32 from $27 at BTIG
02/23/21 Cowen
RealReal price target raised to $29 from $18 at Cowen
02/23/21 Raymond James
RealReal downgraded to Market Perform from Outperform at Raymond James
RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
05/21/20
Fly Intel: Top five analyst initiations
JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

02/16/21 JPMorgan
Nordstrom price target raised to $40 from $34 at JPMorgan
02/10/21 Gordon Haskett
Nordstrom upgraded to Buy from Hold at Gordon Haskett
01/21/21 Deutsche Bank
Nordstrom price target raised to $43 from $24 at Deutsche Bank
01/14/21 Credit Suisse
Nordstrom price target raised to $39 from $26 at Credit Suisse
URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

02/26/21 Deutsche Bank
Urban Outfitters named short-term investment idea at Deutsche Bank
02/10/21 RBC Capital
Urban Outfitters price target raised to $30 from $28 at RBC Capital
01/21/21 Deutsche Bank
Urban Outfitters price target raised to $32 from $31 at Deutsche Bank
01/14/21
Fly Intel: Top five analyst downgrades
ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

01/28/21 JonesTrading
Arena Pharmaceuticals initiated with a Buy at JonesTrading
11/19/20 SMBC Nikko
Arena Pharmaceuticals initiated with an Outperform at SMBC Nikko
11/10/20 RBC Capital
Arena Pharmaceuticals price target lowered to $76 from $80 at RBC Capital
11/02/20 JPMorgan
Arena Pharmaceuticals price target raised to $90 from $71 at JPMorgan
SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

01/19/21 Stifel
Stratasys initiated with a Buy at Stifel
01/15/21 JPMorgan
Stratasys downgraded to Underweight from Neutral at JPMorgan
10/09/20 Berenberg
Stratasys initiated with a Buy at Berenberg
09/24/20
Fly Intel: Top five analyst downgrades
ICAD iCAD
$18.88 /

-0.3 (-1.56%)

02/26/21 B. Riley
iCAD price target raised to $23 from $18 at B. Riley Securities
02/25/21 Oppenheimer
iCAD initiated with an Outperform at Oppenheimer
02/25/21 Craig-Hallum
iCAD price target raised to $22 from $15 at Craig-Hallum
02/25/21 Lake Street
iCAD price target raised to $21 from $17 at Lake Street
ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

02/26/21 HSBC
Airbnb price target raised to $224 from $220 at HSBC
02/26/21 Jefferies
Airbnb price target raised to $210 from $170 at Jefferies
02/26/21 DA Davidson
Airbnb price target raised to $210 from $172 at DA Davidson
02/26/21 Needham
Airbnb represents 'best way to play travel recovery', says Needham
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ICAD iCAD
$18.88 /

-0.3 (-1.56%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

  • 03
    Mar
  • 03
    Mar
  • 04
    Feb
  • 04
    Feb
  • 30
    Dec
  • 10
    Dec
  • 20
    Nov
  • 08
    Oct
  • 13
    Aug
  • 07
    Aug
  • 09
    Jul
  • 28
    May
  • 23
    Apr
ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.